Dr. Tao Xiaodong (陶曉東), joined our Group in December 2016 and has sincethen served as the General Manager of our Company. Dr. Tao was appointed as a Director inDecember 2021 and was further appointed as an executive Director in January 2024. Since May 2019, Dr. Tao has also served as a director of Anhui Imaging Union, one of our subsidiaries. Dr. Tao has over 19 years of experience in healthcare, AI technology and management. Prior to joining our Group, Dr. Tao consecutively served as a computer scientist at the Global Research Center and a China research manager at GE Healthcare China of General Electric Company (a company listed on the New York Stock Exchange under the stock code of GE) from February 2005 to May 2013. From June 2013 to December 2016, Dr. Tao consecutively served as the principal scientist at Philips Research China and chief solutions architect at Philips Healthcare Radiology Solutions of Koninklijke Philips Electronics N.V. (a company listed on the New York Stock Exchange under the stock code of PHG). Dr. Tao holds positions in various healthcare and AI-related associations including serving as a senior member of the Institute of Electrical and Electronics Engineers since May 2014, a member of Chinese Innovative Alliance of Industry, Education, Research and Application of Artificial Intelligence for Medical Imaging (中國醫學影像AI產學研用創新聯 盟) since 2018, a member of China Association of Medical Equipment Management Branch (中 國醫學裝備協會管理分會) since 2018, a member of the Medical Artificial Intelligence Branch of the Chinese Society of Biomedical Engineering (中國生物醫學工程學會醫學人工智能分會) since January 2020, a member of Beijing Medical Association Health Management Branch (北 京醫學會健康管理學分會) since 2019 and a member of the second session of Intelligent Medicine Professional Committee of Chinese Medical Doctor Association (中國醫師協會智慧 醫療專業委員會) since June 2023. Dr. Tao has been appointed as an adjunct professor in biomedical engineering of University of Science and Technology of China (中國科學技術大學) since April 2021. Dr. Tao obtained a bachelor of engineering degree in electrical engineering from University of Science and Technology of China (中國科學技術大學) in the PRC in July 1995, a master of engineering degree in signal and information processing from Institute of Acoustics, Chinese Academy of Sciences (中國科學院聲學研究所) in the PRC in August 1998 and a doctoral degree in electrical and computer engineering from Johns Hopkins University in the United States in May 2005. Dr. Tao was qualified as a senior engineer (正高級工程師) by the Department of Human Resources and Social Security of Anhui Province (安徽省人力資 源與社會保障廳) in November 2019, and was recognized as a “Leading Technical Talent of Anhui Province” (安徽省技術領軍人才) by Anhui Provincial Organization Department of Committee of the Communist Party of China (中國共產黨安徽省委組織部), the Department of Human Resources and Social Security of Anhui Province, Anhui Provincial Development and Reform Commission (安徽省發展和改革委員會) and Department of Science and Technology of Anhui Province (安徽省科學技術廳) in October 2018.

Dr. Liu Qingfeng (劉慶峰), is our non-executive Director and the chairman of the Board. Since December 2021, Dr. Liu has served as a Director and the chairman of the Board. Dr. Liu was further appointed as a non-executive Director in January 2024. Dr. Liu has over 24 years of experience in AI technology and management. Dr. Liu founded iFlytek Group in June 1999 and has since then consecutively served as the president, a director and the chairman of the board of iFlytek. In addition, Dr. Liu has abundant experience in technology industry including serving as the executive director of Anhui Yanzhi Technology Co., Ltd. (安徽言知科技有限公司) since December 2019, a director of Beijing HongYun RongTong Technology Co., Ltd. (北京紅雲融通技術有限公司) since December 2020, the chairman of the board of Antelope Industrial Internet Co., Ltd. (羚羊工業互聯網股 份有限公司) since September 2022, and a director of Chinese Academy of Sciences Holdings Co., Ltd. (中國科學院控股有限公司) from July 2021 to October 2023. Dr. Liu has been a part-time professor and doctoral supervisor of University of Science and Technology of China (中國科學技術大學) since December 2019 and May 2010, respectively. Dr. Liu has been a representative of the 10th, 11th, 12th, 13th and 14th session of the National People’s Congress of the People’s Republic of China (全國人大代表大會) since February 2003. He has also been a member of All-China Youth Federation (中華全國青年聯合 會委員) since June 2005 and the president of Anhui Young Entrepreneurs Association (安徽省 青年企業家協會) since August 2018. Dr. Liu was awarded the “Business Person of the Year” (年度經濟人物獎) by the China Central Television in December 2013 and the “100 Outstanding Private Entrepreneurs during the 40 Years of Reform and Opening” (改革開放40年百名傑出民 營企業家) by the United Front Work Department of CPC Central Committee (中共中央統一戰 線工作部) and All-China Federation of Industry and Commerce (中華全國工商業聯合會) in October 2018. Dr. Liu obtained a bachelor of engineering degree in electrical engineering from University of Science and Technology of China (中國科學技術大學) in the PRC in July 1995, a master of engineering degree in information and communication engineering from University of Science and Technology of China (中國科學技術大學) in the PRC in December 1998, and a doctor of engineering degree in information and communication engineering from University of Science and Technology of China (中國科學技術大學) in the PRC in December 2003.

Mr. Zhao Zhiwei (趙志偉), is our non-executive Director. Mr. Zhao has served as our Director since he joined our Group in May 2016, and has since then held directorships in various subsidiaries of our Company including Beijing Huiji, Yinchuan Xunfei, Lvliang Xunfei, Pu’er Xunfei until December 2023. Mr. Zhao was further appointed as a non-executive Director in January 2024. Mr. Zhao has served as a director of Anhui Imaging Union since August 2021. Mr. Zhao has over 23 years of experience in AI technology and management, he joined iFlytek Group in July 2000 and has since then consecutively served as speech synthesis researcher, director of speech synthesis R&D, R&D director, the deputy executive director of platform and embedded business division, Senior Vice President of iFlytek. In addition, Mr. Zhao has also served as the executive director of Xi’an iFlytek Super Brain Information Technology Co., Ltd. (西安訊飛超腦信息科技有限公司), a subsidiary of iFlytek, since June 2018, and a director of Kexun Jialian Information Technology Co., Ltd. (科訊嘉聯信息技術有 限公司), a company owned by iFlytek as to 13.2%, since February 2016. Mr. Zhao obtained a bachelor of science degree in theoretical and applied mechanics and a bachelor of engineering degree in computer science and technology from University of Science and Technology of China (中國科學技術大學) in the PRC in June 2000.

Mr. Duan Dawei (段大為), is our non-executive Director. Mr. Duan joined our Group in December 2021 and has since then served as a director of our Company. Mr. Duan was further appointed as a non-executive Director in January 2024. Mr. Duan joined iFlytek Group in November 2017 and has since then consecutively served as the Chief Financial Officer, Vice President and director of iFlytek. Mr. Duan has also served as the chairman of the board and general manager of Tianjin iFlytek Finance Leasing Co., Ltd. (天津訊飛融資租賃有 限公司), a subsidiary of iFlytek, since November 2019. Mr. Duan has over 30 years of experience in financial management, securities investment and international cooperation of large conglomerate groups. Mr. Duan’s previous working experience includes: serving as the assistant of general manager of Jilin Chemical Industrial Group (吉林化工集團) from July 1993 to June 2000, the finance minister of Jilin Electronics Group (吉林省電子集團) from June 2000 to October 2003, and the Senior Vice President and financial director of SANY Group Co., Ltd. (三一集團有限公司) and SANY Heavy Industry Co., Ltd. (三一重工股份有限公司, a company listed on the Shanghai Stock Exchange under the stock code of 600031) from December 2003 to November 2017. Mr. Duan has been a part-time master’s tutor at the Shanghai National Accounting Institute (上海國家會計學院) and the School of Accounting of Dongbei University of Finance and Economics (東北財經大學會計學院) since May 2019. Mr. Duan was awarded the “China’s CFO of the Year” (中國CFO年度人物) by New Financial Management Magazine (新理財雜誌) in April 2008 and the “China Best CFO Leadership Award” (中國卓越CFO領導力大獎) by Korn Ferry (光輝國際), Shanghai National Accounting Institute (上海國家會計學院) and the Association of Charted Certified Accountants in September 2019. Mr. Duan obtained a bachelor’s and master’s degree in economics from the Dongbei University of Finance & Economics (東北財經大學) in the PRC in July 1993 and November 1999, respectively, and a master’s degree in business administration from the Missouri State University in the United States in July 2010.

Prof. Wang Yang (汪揚), is our independent non-executive Director. Prof. Wang was appointed as our independent non-executive Director on August 12, 2024 with effect from December 6, 2024. Since joining the Hong Kong University of Science and Technology (“HKUST”) in August 2014, Prof. Wang served as the head of the Department of Mathematics from August 2014 to October 2016, the dean of the School of Science from November 2016 to September 2020 and has served as the director of the HKUST Big Data for Biological Intelligence Laboratory and an associate director of the HKUST Big Data Institute since May 2016, as well as the Vice-President for Institutional Advancement since October 2020. Prof. Wang has been awarded the title of Chair Professor of Department of Mathematics at HKUST since August 2014. His other previous working experience includes consecutively serving as an assistant professor, an associate professor and a professor in mathematics, an adjunct professor of The Logistics Institute, an undergraduate director of the School of Mathematics, and an associate chair of the School of Mathematics at Georgia Institute of Technology from July 1989 to May 2007, serving as the department chair of Mathematics at Michigan State University from August 2007 to August 2014, and serving as a program director at the United States National Science Foundation from September 2006 to August 2007. Prof. Wang obtained his bachelor’s degree in mathematics from the University of Science and Technology of China (中國科學技術大學) in the PRC in July 1983, and his Master of Science degree and Doctorate of Philosophy degree in mathematics from Harvard University in the United States in June 1988 and March 1990, respectively.

Prof. Zhao Huifang (趙惠芳), is our independent non-executive Director. Prof. Zhao was appointed as our independent non-executive Director on January 25, 2024. Prof. Zhao has over 46 years of experience in accounting and financial management. Since July 1977, she has been with Hefei University of Technology (合肥工業大學), where she consecutively served as a teaching assistant in economics for six years, lecturer, associate professor and professor in accounting for over 40 years. In addition, Prof. Zhao has also consecutively served as deputy dean, dean and secretary of the party committee of the school of management of Hefei University of Technology from June 1990 to February 2011, the director of MBA/MPA management centre of Hefei University of Technology from May 2007 to February 2014, and the director of institute of financial management of Hefei University of Technology from July 2007 to February 2017. Prof. Zhao has abundant working experience as a director and member/chairwoman of the audit committee of listed companies, including serving as: (i) an independent non-executive director and a member and the chairwoman of the audit committee of An Hui Wenergy Company Limited. (安徽皖能股份有限公司, a company listed on the Shenzhen Stock Exchange under the stock code of 000543) from June 2003 to May 2009, (ii) an independent non-executive director of Anhui Huilong Agricultural Means of Production Co., Ltd. (安徽輝 隆農資股份有限公司, a company listed on the Shenzhen Stock Exchange under the stock code of 002556) from November 2009 to February 2015 and the chairwoman of its audit committee from December 2011 and February 2015, (iii) an independent non-executive director and the chairwoman of the audit committee of Anhui Jianghuai Automobile Group Co., Ltd. (安徽江 淮汽車股份有限公司, a company listed on the Shanghai Stock Exchange under the stock code of 600418) from March 2009 to July 2015, (iv) an independent non-executive director of Hefei Urban Construction Development Co., Ltd. (合肥城建股份有限公司, a company listed on the Shenzhen Stock Exchange under the stock code of 002208) from January 2009 to September 2015 and the chairwoman of its audit committee from February 2012 to September 2015, (v) an independent non-executive director of Hua’an Securities Co., Ltd. (華安證券股份有限公司, a company listed on the Shanghai Stock Exchange under the stock code of 600909) from January 2013 to May 2019 and a member of its audit committee from March 2016 to April 2019, (vi) an independent non-executive director of Anhui Ankai Automobile Co., Ltd. (安徽 安凱汽車股份有限公司, a company listed on the Shenzhen Stock Exchange under the stock code of 000868) from November 2015 to March 2022 and the chairwoman of its audit committee from October 2016 to March 2022, (vii) an independent non-executive director and a member of the audit committee of Time Publishing and Media Co., Ltd. (時代出版傳媒股份 有限公司, a company listed on the Shanghai Stock Exchange under the stock code of 600551) from November 2015 to January 2023, (viii) an independent non-executive director and the chairwoman of the audit committee of iFlytek Co., Ltd. (科大訊飛股份有限公司, a company listed on the Shenzhen Stock Exchange under the stock code of 002230) from January 2017 to January 2023, (ix) an independent non-executive director and a member of the audit committee of Weichai Power Co., Ltd. (濰柴動力股份有限公司, a company listed on the Hong Kong Stock Exchange under the stock code of 2338 and Shenzhen Stock Exchange under the stock code of 000338) from June 2020 to June 2023, (x) an independent non-executive director and a member of the audit committee of Anhui Gourgen Traffic Construction Co., Ltd. (安徽交通建設股份有 限公司, a company listed on the Shanghai Stock Exchange under the stock code of 603815) since April 2023 and (xi) an independent non-executive director and a member of the audit committee of Sinomach General Machinery Science & Technology Co., Ltd. (國機通用機械科 技股份有限公司, a company listed on the Shanghai Stock Exchange under the stock code of 600444) since September 2019. Prof. Zhao was granted a number of awards in the areas including accounting and financial management. The “Corporate Accounting” (《企業會計學》) of which she acted as editor-in-chief was granted the second prize for “Excellent Higher Education Textbooks” (全 國普通高等學校優秀教材) by Ministry of Education of the People’s Republic of China (中華 人民共和國教育部) in October 2002 and her project named “Study on the Knowledge System of Management Professional Finance (Non-accounting) and Accounting” (管理類(非會計)專業 財務與會計知識體系研究) was granted the first prize of “Anhui Provincial Outstanding Teaching Achievement Award” (安徽省優秀教學成果) by Department of Education of Anhui Province (安徽省教育廳) in March 2005. In addition, Prof. Zhao was granted the “Special Government Allowances” (安徽省政府特殊津貼) by Anhui Municipal People’s Government (安徽省人民政府) in July 2008. Prof. Zhao graduated in political theory from Hefei University of Technology (合肥工業 大學) in the PRC in August 1977, engaged in advanced study of economics in Nanjing University (南京大學) in the PRC from September 1979 to July 1980, and completed study in teaching assistant program of Anhui University (安徽大學) focusing on economics in the PRC in November 1986, and she conducted collaborative research in accounting at the faculty of business of Kurume University in Japan from November 1998 to February 1999.

Mr. Tan Ching (談慶), is our independent non-executive Director. Mr. Tan was appointed as our independent non-executive Director on January 25, 2024. Mr. Tan has over 35 years of experience in technology industry, investment and management. His previous working experience includes: serving as (i) a manager in Shenzhen Electronics Group Co., Ltd. (深圳市賽格集團有限公司) from September 1988 to September 1992, (ii) an engineering manager in GE Healthcare U.S. of General Electric Company (a company listed on the New York Stock Exchange under the stock code of GE) from September 1994 to September 1999, (iii) an investment manager in Qifeng Fund (啟峰創投) from February 2000 to January 2001, (iv) a manager in Booz Allen Hamilton from January 2001 to March 2002, (v) a Vice President and General Manager of core imaging in GE Healthcare China of General Electric Company from March 2002 to December 2006, and (vi) director, General Manager and Chief Representative of China in Siguler Guff & Co., LLC from December 2006 to October 2012. In addition, Mr. Tan has served as (i) the general manager of Shanghai Jiachen Private Equity Fund Management Co., Ltd. (上海甲辰私募基金管理有限公 司) since November 2012, (ii) a director of Power MED Limited (能金有限公司) since December 2014, (iii) a supervisor of Beijing Biomarker Technologies Co., Ltd. (北京百邁客生 物科技有限公司) since June 2015, (iv) an executive director and general manager of Guangzhou Jinyongji Investment Consulting Co., Ltd. (廣州市金墉基投資諮詢有限公司) since November 2015, (v) an executive director and general manager of Shanghai Zhenjin Investment Co. Ltd. (上海臻津投資有限公司) since December 2015, (vi) a director of Shenzhen Feisen Technology Co., Ltd. (深圳市菲森科技有限公司) since September 2016, (vii) a director of Biohit Healthcare (Hefei) Co., Ltd. (必歐瀚生物技術(合肥)有限公司) since January 2018, (viii) a non-executive director of Jenscare Scientific Co., Ltd. (寧波健世科技股 份有限公司), a company listed on the Hong Kong Stock Exchange under the stock code of 9877, since March 2019, (ix) a director of HuidaGene (Shanghai) Biotechnology Co. Ltd. (輝 大(上海)生物科技有限公司) since December 2019, (x) an executive director of Shanghai Jiachen Enterprise Management Consulting Co. Ltd. (上海迦辰企業管理諮詢有限公司) since July 2020, (xi) a director of Hangzhou Jieyi Biotechnology Co., Ltd. (杭州傑毅生物技術有限 公司) since January 2021, (xii) an executive director of Shanghai Fichen Investment Management Co., Ltd. (上海斐辰投資管理有限公司) since January 2021, (xiii) an executive director and general manager of Shanghai Chenxu Enterprise Management Consulting Co., Ltd. (上海辰續企業管理諮詢有限公司) since August 2021, (xiv) a director of Creative Biosciences (Guangzhou) Co., Ltd. (廣州康立明生物科技股份有限公司) since September 2021, (xv) a director of Hangzhou Ezgene Technology Co., Ltd. (杭州易速微控基因技術有限 公司) since January 2022, (xvi) a director of BMC Medical Co., Ltd. (北京怡和嘉業醫療科技 股份有限公司), a company listed on the Shenzhen Stock Exchange under the stock code of 301367, since September 2018, (xvii) a director of Shanghai Wancheng Biotechnology Co., Ltd. (上海綰塍生物科技有限公司) since January 2022, (xviii) a director of Shenzhen Congheng Technology Co., Ltd. (深圳市聰衡科技有限公司) since October 2022. Mr. Tan was recognized as (i) a “the Healthcare Investor of the Year (Excellence Ranking List)” (卓悅榜–年度醫療健康投資人) by Haoyue Capital (浩悅資本) in March 2020, March 2021, April 2022 and April 2023, (ii) a “Top Ten Elite IVD Investors of the Year” (Top 10年 度IVD精英投資人) by Chujie Technology (觸界科技) in December 2021, (iii) a “Top 100 China Investors” (投資界TOP 100投資人) by Zero2IPO Holdings Inc. (清科創業控股有限公 司) in August 2022 and July 2023, and (iv) a “Top 100 China’s Best Venture Investor of Year 2022-2023” (2022-2023年度中國最佳創業投資人Top 100) by CVCapital (投中資本) in November 2023. Mr. Tan obtained a master’s degree in business management from University of Chicago the U.S. in March 2000.